Pacira Pharmaceuticals reported $57.94M in EBITDA for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Aerie Pharmaceuticals AERI:US $ 53.36M 84.13M
Depomed DEPO:US $ 13.35M 17.87M
Nektar Therapeutics NKTR:US $ -109.47M 0.5M
Teva Pharmaceutical TEVA:IT 1.29B 151M
Xoma XOMA:US $ -2063000 32.43M
Zoetis ZTS:US $ 714M 131M